title: Estrogen receptor activation, TNF-α, and endothelial dysfunction: can we keep our interest in estrogens awake?
authors.affiliation: 1Out Patient Clinics and Preventive Cardiology, LDL apheresis service, Onassis Cardiac Surgery Center Athens, Greece.
authors.forename: Genovefa D
authors.initials: GD
authors.lastname: Kolovou
authors.forename: Sophie
authors.initials: S
authors.lastname: Mavrogeni
mesh_terms: D004730:Endothelium, Vascular / Q000187:drug effects*; D006801:Humans; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism*; D052250:Nitric Oxide Synthase Type III / Q000378:metabolism*; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism*; D011960:Receptors, Estrogen / Q000378:metabolism*; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*
chemical_list: D011960:Receptors, Estrogen; D014409:Tumor Necrosis Factor-alpha; D052250:Nitric Oxide Synthase Type III; D051057:Proto-Oncogene Proteins c-akt; D020780:Matrix Metalloproteinase 9